{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T21:56:03Z","timestamp":1792446963587,"version":"4.5.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T00:00:00Z","timestamp":1766793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008781","name":"Pomorski Uniwersytet Medyczny W Szczecinie","doi-asserted-by":"publisher","award":["WFB-409\/S\/2023"],"award-info":[{"award-number":["WFB-409\/S\/2023"]}],"id":[{"id":"10.13039\/501100008781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004837","name":"Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["CNS2023\\u2013145136"],"award-info":[{"award-number":["CNS2023\\u2013145136"]}],"id":[{"id":"10.13039\/501100004837","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.biopha.2025.118958","type":"journal-article","created":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T15:23:04Z","timestamp":1770218584000},"page":"118958","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Tunable PEGylated albumin nanocarriers enhance 5-FU cytotoxic selectivity and modulate oxidative and immune stress in colorectal cancer model"],"prefix":"10.1016","volume":"196","author":[{"given":"Maria","family":"D\u0105bkowska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Kosiorowska-Kraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0996-0467","authenticated-orcid":false,"given":"Alicja","family":"Szatanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4810-7632","authenticated-orcid":false,"given":"Kacper","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9098-9101","authenticated-orcid":false,"given":"Monica","family":"Mart\u00ednez-Orts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1776-4296","authenticated-orcid":false,"given":"Silvia","family":"Pujals","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Olszewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamila","family":"Pukacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118958_bib1","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/wnan.1157","article-title":"Recent advances in stealth coating of nanoparticle drug delivery systems","volume":"4","author":"Amoozgar","year":"2012","journal-title":"Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2025.118958_bib2","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.2147\/IJN.S500997","article-title":"Wolf in Sheep\u2019s clothing: taming cancer\u2019s resistance with human serum albumin?","volume":"20","author":"Stukan","year":"2025","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118958_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.130726","article-title":"In vitro and in vivo characterization of human serum albumin-based PEGylated nanoparticles for BDNF and NT3 codelivery","volume":"265","author":"D\u0105bkowska","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118958_bib4","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.febslet.2008.04.057","article-title":"The antioxidant properties of serum albumin","volume":"582","author":"Roche","year":"2008","journal-title":"FEBS Lett."},{"key":"10.1016\/j.biopha.2025.118958_bib5","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bbagen.2004.08.001","article-title":"The\u00a0?-Helical membrane spanning domain of cytochrome interacts with cytochrome P450 via nonspecific interactions","volume":"1674","author":"Mulrooney","year":"2004","journal-title":"Biochim. Biophys. Acta BBA Gen. Subj."},{"key":"10.1016\/j.biopha.2025.118958_bib6","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/sj.bjp.0707251","article-title":"Physiological and pathological changes in the redox state of human serum albumin critically influence its binding properties","volume":"151","author":"Oettl","year":"2007","journal-title":"Br. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118958_bib7","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ijbiomac.2012.07.014","article-title":"Nanoparticles based on albumin: preparation, characterization and the use for 5-flurouracil delivery","volume":"51","author":"Wilson","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118958_bib8","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1080\/17435889.2024.2350356","article-title":"Nanomedicine for colon-targeted drug delivery: strategies focusing on inflammatory bowel disease and colon cancer","volume":"19","author":"Kumar","year":"2024","journal-title":"Nanomed"},{"key":"10.1016\/j.biopha.2025.118958_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1582659","article-title":"Targeted and intelligent nano-drug delivery systems for colorectal cancer treatment","volume":"13","author":"Chai","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118958_bib10","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s12032-025-02670-z","article-title":"Nanomedicine innovations in colon and rectal cancer: advances in targeted drug and gene delivery systems","volume":"42","author":"Razzaq","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.biopha.2025.118958_bib11","article-title":"Optimized mesalamine-loaded polyelectrolyte complex nanoparticles for targeted colon delivery in inflammatory bowel disease treatment: a central composite design approach","volume":"8","author":"Fatima","year":"2025","journal-title":"Mater"},{"key":"10.1016\/j.biopha.2025.118958_bib12","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1073\/pnas.0608582104","article-title":"Understanding the nanoparticle\u2013protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles","volume":"104","author":"Cedervall","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.biopha.2025.118958_bib13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.addr.2009.03.009","article-title":"Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy","volume":"61","author":"Aggarwal","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118958_bib14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/j.nantod.2016.10.005","article-title":"Emerging understanding of the protein corona at the nano-bio interfaces","volume":"11","author":"Mahmoudi","year":"2016","journal-title":"Nano Today"},{"key":"10.1016\/j.biopha.2025.118958_bib15","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/nnano.2012.207","article-title":"Biomolecular coronas provide the biological identity of nanosized materials","volume":"7","author":"Monopoli","year":"2012","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.biopha.2025.118958_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4143\/crt.2009.41.1.1","article-title":"Advances of cancer therapy by nanotechnology","volume":"41","author":"Wang","year":"2009","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.biopha.2025.118958_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/nbt.3330","article-title":"Principles of nanoparticle design for overcoming biological barriers to drug delivery","volume":"33","author":"Blanco","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.biopha.2025.118958_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.molimm.2005.02.006","article-title":"Complement activation and protein adsorption by carbon nanotubes","volume":"43","author":"Salvadormorales","year":"2006","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.biopha.2025.118958_bib19","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S1359-6446(05)03575-0","article-title":"PEGylation, successful approach to drug delivery","volume":"10","author":"Veronese","year":"2005","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.biopha.2025.118958_bib20","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1021\/acs.bioconjchem.2c00262","article-title":"Moving protein PEGylation from an art to a data science","volume":"33","author":"Mao","year":"2022","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2025.118958_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1021\/acs.bioconjchem.5b00143","article-title":"Cys34-PEGylated human serum albumin for drug binding and delivery","volume":"26","author":"Mehtala","year":"2015","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2025.118958_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3052175","article-title":"Preparation of drug-loaded albumin nanoparticles and its application in cancer therapy","volume":"2022","author":"Meng","year":"2022","journal-title":"J. Nanomater"},{"key":"10.1016\/j.biopha.2025.118958_bib23","first-page":"7","article-title":"Augmenting drug\u2013carrier compatibility improves tumour nanotherapy efficacy","author":"Zhao","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118958_bib24","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrc1074","article-title":"5-Fluorouracil: mechanisms of action and clinical strategies","volume":"3","author":"Longley","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biopha.2025.118958_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10717544.2022.2154410","article-title":"Treatment Efficacy of Low-Dose 5-Fluorouracil with Ultrasound in Mediating 5-Fluorouracil-Loaded Microbubble Cavitation in Head and Neck Cancer","volume":"30","author":"Liao","year":"2023","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2025.118958_bib26","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jconrel.2010.08.027","article-title":"To exploit the tumor microenvironment: passive and active tumor targeting of nanocarriers for anti-cancer drug delivery","volume":"148","author":"Danhier","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118958_bib27","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ijbiomac.2016.05.032","article-title":"A Simple improved desolvation method for the rapid preparation of albumin nanoparticles","volume":"91","author":"Jahanban-Esfahlan","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2025.118958_bib28","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.2147\/IJN.S223368","article-title":"Physical PEGylation enhances the cytotoxicity of 5-fluorouracil-loaded PLGA And PCL nanoparticles","volume":"14","author":"Ashour","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118958_bib29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.colsurfb.2014.02.053","article-title":"Mechanism of immonoglobulin G adsorption on mica-AFM and electrokinetic studies","volume":"118","author":"D\u0105bkowska","year":"2014","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118958_bib30","doi-asserted-by":"crossref","first-page":"17846","DOI":"10.1021\/acs.jpcc.8b04916","article-title":"Lysozyme monolayers at polymer microparticles: electrokinetic characteristics and modeling","volume":"122","author":"D\u0105bkowska","year":"2018","journal-title":"J. Phys. Chem. C."},{"key":"10.1016\/j.biopha.2025.118958_bib31","first-page":"19","article-title":"The role of the electrokinetic charge of neurotrophis-based nanocarriers: protein distribution, toxicity, and oxidative stress in in vitro setting","author":"D\u0105bkowska","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.biopha.2025.118958_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.colsurfa.2016.03.060","article-title":"Monolayers of silver nanoparticles on positively charged polymer microspheres","volume":"499","author":"Sadowska","year":"2016","journal-title":"Colloids Surf. Physicochem. Eng. Asp."},{"key":"10.1016\/j.biopha.2025.118958_bib33","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"Schneider","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.biopha.2025.118958_bib34","unstructured":"The MathWorks, Inc. MATLAB 2024."},{"key":"10.1016\/j.biopha.2025.118958_bib35","first-page":"11","article-title":"Mapping and identification of soft corona proteins at nanoparticles and their impact on cellular association","author":"Mohammad-Beigi","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.biopha.2025.118958_bib36","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1021\/acs.bioconjchem.8b00404","article-title":"Encapsulation and systemic delivery of 5-fluorouracil conjugated with silkworm pupa derived protein nanoparticles for experimental lymphoma cancer","volume":"29","author":"Reneeta","year":"2018","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.biopha.2025.118958_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1590\/S1984-82502013000100013","article-title":"Development and validation of an HPLC method for the determination of fluorouracil in polymeric nanoparticles","volume":"49","author":"Mattos","year":"2013","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118958_bib38","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1039\/c1ay05148b","article-title":"Development and validation of a high-performance liquid chromatography (HPLC) method for the determination of human serum albumin (HSA) in medical devices","volume":"3","author":"Eertmans","year":"2011","journal-title":"Anal. Methods"},{"key":"10.1016\/j.biopha.2025.118958_bib39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(03)00134-0","article-title":"Optimization of the preparation process for human serum albumin (HSA) nanoparticles","volume":"257","author":"Langer","year":"2003","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118958_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2025.100218","article-title":"Serum albumin nanoparticles: ligand functionalization for enhanced targeted therapeutics in precision medicine","volume":"27","author":"Shahapurmath","year":"2025","journal-title":"Med. Drug Discov."},{"key":"10.1016\/j.biopha.2025.118958_bib41","doi-asserted-by":"crossref","first-page":"728","DOI":"10.34172\/apb.2021.082","article-title":"The effect of length and structure of attached polyethylene glycol chain on hydrodynamic radius, and separation of PEGylated human serum albumin by chromatography","volume":"11","author":"Akbarzadehlaleh","year":"2020","journal-title":"Adv. Pharm. Bull."},{"key":"10.1016\/j.biopha.2025.118958_bib42","article-title":"Guideline on the requirements to the chemical and pharmaceutical quality documentation concerning investigational medicinal products in","author":"European Medicines Agency (EMA)","year":"2022","journal-title":"Clin. Trials"},{"key":"10.1016\/j.biopha.2025.118958_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118958_bib44","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1007\/s10876-024-02666-1","article-title":"Bovine serum albumin nanoparticles as a proposed drug formulation for the delivery of 10H-2,7-diazaphenothiazine","volume":"35","author":"Kulig","year":"2024","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.biopha.2025.118958_bib45","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.1021\/acs.biomac.3c00363","article-title":"Dopamine-conjugated bovine serum albumin nanoparticles containing pH-responsive catechol-V(III) coordination for in vitro and in vivo drug delivery","volume":"24","author":"Argitekin","year":"2023","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.biopha.2025.118958_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.molliq.2023.123293","article-title":"Interactions and characterization of Zein-BSA nanoparticles: multi-spectral analysis and molecular simulations","volume":"391","author":"Zhang","year":"2023","journal-title":"J. Mol. Liq."},{"key":"10.1016\/j.biopha.2025.118958_bib47","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.colsurfb.2012.07.007","article-title":"Mechanism of HSA adsorption on mica determined by streaming potential, AFM and XPS measurements","volume":"101","author":"D\u0105bkowska","year":"2013","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118958_bib48","article-title":"Effect of zeta potential on the properties of nano-drug delivery systems - A review (Part 2)","volume":"12","author":"Honary","year":"2013","journal-title":"Trop. J. Pharm. Res."},{"key":"10.1016\/j.biopha.2025.118958_bib49","doi-asserted-by":"crossref","first-page":"7299","DOI":"10.1021\/la9041502","article-title":"Conformational studies of covalently grafted poly(Ethylene Glycol) on modified solid matrices using X-ray photoelectron spectroscopy","volume":"26","author":"Damodaran","year":"2010","journal-title":"Langmuir"},{"key":"10.1016\/j.biopha.2025.118958_bib50","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1021\/acs.nanolett.0c03756","article-title":"Brush conformation of polyethylene glycol determines the stealth effect of nanocarriers in the low protein adsorption regime","volume":"21","author":"Li","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.biopha.2025.118958_bib51","doi-asserted-by":"crossref","first-page":"10748","DOI":"10.1039\/D1NR02065J","article-title":"Effects of polyethylene glycol on the surface of nanoparticles for targeted drug delivery","volume":"13","author":"Shi","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2025.118958_bib52","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jps.2600840420","article-title":"Stealth Me. PEG-PLA nanoparticles avoid uptake by the mononuclear phagocytes system","volume":"84","author":"Bazile","year":"1995","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118958_bib53","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijpharm.2005.10.010","article-title":"Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles","volume":"307","author":"Owensiii","year":"2006","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2025.118958_bib54","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jconrel.2025.01.035","article-title":"Albumin-based delivery systems: recent advances, challenges, and opportunities","volume":"380","author":"Murphy","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.biopha.2025.118958_bib55","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1039\/C5NR07161E","article-title":"Nanoformulation and encapsulation approaches for poorly water-soluble drug nanoparticles","volume":"8","author":"Wais","year":"2016","journal-title":"Nanoscale"},{"key":"10.1016\/j.biopha.2025.118958_bib56","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.addr.2013.11.009","article-title":"Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology","volume":"66","author":"Bertrand","year":"2014","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2025.118958_bib57","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2011.07.031","article-title":"Albumin-based nanoparticles as potential controlled release drug delivery systems","volume":"157","author":"Elzoghby","year":"2012","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.biopha.2025.118958_bib58","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.jchromb.2009.02.021","article-title":"Determination of dissociation constants between polyelectrolytes and proteins by affinity capillary electrophoresis","volume":"877","author":"Anderot","year":"2009","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.biopha.2025.118958_bib59","doi-asserted-by":"crossref","first-page":"6414","DOI":"10.1016\/j.actbio.2013.01.006","article-title":"Investigation of the interaction between poly(Ethylene Glycol) and protein molecules using low field nuclear magnetic resonance","volume":"9","author":"Wu","year":"2013","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2025.118958_bib60","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0026-895X(25)10691-3","article-title":"The characterization of two specific drug binding sites on human serum albumin","volume":"11","author":"Sudlow","year":"1975","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2025.118958_bib61","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1038\/bjc.1995.519","article-title":"Differences in resistance to 5-Fluorouracil as a function of cell cycle delay and not apoptosis","volume":"72","author":"Pickard","year":"1995","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.biopha.2025.118958_bib62","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2407-8-103","article-title":"Pharmacokinetic characteristics and anticancer effects of 5-fluorouracil loaded nanoparticles","volume":"8","author":"Li","year":"2008","journal-title":"BMC Cancer"},{"key":"10.1016\/j.biopha.2025.118958_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.colsurfb.2017.04.020","article-title":"Stealth recombinant human serum albumin nanoparticles conjugating 5-fluorouracil augmented drug delivery and cytotoxicity in human colon cancer, HT-29 cells","volume":"155","author":"Sharma","year":"2017","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118958_bib64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jsps.2016.05.010","article-title":"Prolonged exposure of colon cancer cells to 5-fluorouracil nanoparticles improves its anticancer activity","volume":"25","author":"Tawfik","year":"2017","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2025.118958_bib65","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3390\/pharmaceutics13050755","article-title":"Bio- and hemo-compatible silk fibroin PEGylated nanocarriers for 5-fluorouracil chemotherapy in colorectal cancer: in vitro studies","volume":"13","author":"Hudi\u021b\u0103","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2025.118958_bib66","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1208\/s12248-015-9761-5","article-title":"Poly(Butylcyanoacrylate) and Poly(\u03b5-Caprolactone) nanoparticles loaded with 5-fluorouracil increase the cytotoxic effect of the drug in experimental colon cancer","volume":"17","author":"Ortiz","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.biopha.2025.118958_bib67","doi-asserted-by":"crossref","unstructured":"Caco-2 Cell Line. In The Impact of Food Bioactives on Health; Springer International Publishing: Cham, 2015; pp. 103\u2013111 ISBN 978-3-319-15791-7.","DOI":"10.1007\/978-3-319-16104-4_10"},{"key":"10.1016\/j.biopha.2025.118958_bib68","doi-asserted-by":"crossref","first-page":"9259","DOI":"10.2147\/IJN.S223368","article-title":"Physical PEGylation enhances the cytotoxicity of 5-fluorouracil-loaded PLGA And PCL nanoparticles","volume":"14","author":"Ashour","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.biopha.2025.118958_bib69","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.3390\/nu17071230","article-title":"Astaxanthin mitigates 5-fluorouracil-induced hepatotoxicity and oxidative stress in male rats","volume":"17","author":"\u00d6zt\u00fcrk","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/j.biopha.2025.118958_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111527","article-title":"Protein corona components of polyethylene glycol-conjugated organosilica nanoparticles modulates macrophage uptake","volume":"199","author":"Kim","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.biopha.2025.118958_bib71","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.xphs.2023.11.001","article-title":"Treatment-induced and pre-existing anti-peg antibodies: prevalence, clinical implications, and future perspectives","volume":"113","author":"Gaballa","year":"2024","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2025.118958_bib72","doi-asserted-by":"crossref","first-page":"14022","DOI":"10.1021\/acsnano.1c05922","article-title":"Polyethylene glycol immunogenicity: theoretical, clinical, and practical aspects of anti-polyethylene glycol antibodies","volume":"15","author":"Chen","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.biopha.2025.118958_bib73","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s40883-021-00198-y","article-title":"Clinical relevance of pre-existing and treatment-induced anti-poly(Ethylene Glycol) antibodies","volume":"8","author":"Freire Haddad","year":"2022","journal-title":"Regen. Eng. Transl. Med."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332225011527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T14:41:11Z","timestamp":1781880071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332225011527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":73,"alternative-id":["S0753332225011527"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118958","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tunable PEGylated albumin nanocarriers enhance 5-FU cytotoxic selectivity and modulate oxidative and immune stress in colorectal cancer model","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118958","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118958"}}